Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

RECURSION PHARMACEUTICALS, INC. (RXRX)

$3.70 +3.35% NASDAQ: RXRX · 15-min delayed
  • SALT LAKE CITY, Utah
  • Public · NASDAQ: RXRX
  • 600 employees
$1.6BMarket cap
$74.7MRevenue · FY2025
-$644.8MNet income
600Employees
RXRXNASDAQ
2021IPO

About RECURSION PHARMACEUTICALS, INC.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$74.7M
Net income
-$644.8M
Total assets
$1.5B
Market cap
$1.6B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: RXRX
$3.70 +3.35%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.84 $6.79

52-week range

Market cap
$1.6B
Shares outstanding
424.6M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Apr 16, 2021

Recursion Pharmaceuticals, Inc. (RXRX) Stock Price

  • Reported a net loss of $644.8M in FY2025.
  • Trading 46% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review RECURSION PHARMACEUTICALS, INC..

Write a review
Newsroom

News about RECURSION PHARMACEUTICALS, INC.

News & sentiment via Polygon.io

FAQ

Recursion Pharmaceuticals, Inc.: frequently asked questions

Is Recursion Pharmaceuticals, Inc. an American company?

Recursion Pharmaceuticals, Inc. is a US-based company headquartered in Salt Lake City, Utah, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Recursion Pharmaceuticals, Inc. headquartered?

Recursion Pharmaceuticals, Inc. is headquartered in Salt Lake City, Utah, United States.

Is Recursion Pharmaceuticals, Inc. publicly traded?

Yes — Recursion Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol RXRX on the NASDAQ.

What does Recursion Pharmaceuticals, Inc. do?

Recursion Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →